Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-05-01 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
S | Common Stock | D | 5000 | $20.15 - $20.15 | $100,749 |
| 2024-04-01 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
S | Common Stock | D | 5000 | $24.33 - $25.02 | $121,912 |
| 2024-03-13 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
S | Common Stock | D | 723 | $28.33 - $28.33 | $20,482 |
| 2024-03-13 | Akero Therapeutics, Inc. | White William Ric...
(Chief Financial Officer) |
S | Common Stock | D | 724 | $28.33 - $28.33 | $20,510 |
| 2024-03-13 | Akero Therapeutics, Inc. | Cheng Andrew
(President and CEO) |
S | Common Stock | D | 1969 | $28.33 - $28.33 | $55,781 |
| 2024-03-13 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
S | Common Stock | D | 651 | $28.33 - $28.33 | $18,442 |
| 2024-03-13 | Akero Therapeutics, Inc. | Rolph Timothy
(Chief Scientific Officer) |
S | Common Stock | D | 619 | $28.33 - $28.33 | $17,536 |
| 2024-03-04 | Akero Therapeutics, Inc. | Cheng Andrew
(President and CEO) |
S | Common Stock | D | 75000 | $31.40 - $36.28 | $2,465,059 |
| 2024-03-04 | Akero Therapeutics, Inc. | Cheng Andrew
(President and CEO) |
M | Common Stock | A | 75000 | $16.00 - $21.10 | $1,288,061 |
| 2024-03-04 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
S | Common Stock | D | 20646 | $35.49 - $35.49 | $732,726 |
| 2024-03-04 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
M | Common Stock | A | 20646 | $6.36 - $21.09 | $288,124 |
| 2024-01-02 | Akero Therapeutics, Inc. | Cheng Andrew
(President and CEO) |
M | Common Stock | A | 40000 | $0.61 - $0.61 | $24,600 |
| 2023-12-14 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
S | Common Stock | D | 597 | $20.76 - $20.76 | $12,393 |
| 2023-11-17 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
S | Common Stock | D | 30000 | $14.68 - $14.68 | $440,259 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |